Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| EC Approves BMS and AstraZeneca's Type 2 Diabetes Therapy for Renally Impaired ... - Genetic Engineering News |
 |
 |
|
Genetic Engineering News The new approval was granted on the basis of a 12-week study comparing Onglyza with placebo in 170 patients with type 2 diabetes and renal impairment. 98.2% of patients included were already being treated with other antihyperglycemic medications. |
